Relationship between susceptibility to antimicrobials and virulence factors in paediatric Escherichia coli isolates.

Abstract:

:The in vitro susceptibilities to several antibiotics of 136 Escherichia coli strains containing virulence factors isolated from children with urinary tract infection were analysed. Escherichia coli strains were analysed by multiplex polymerase chain reaction for genes encoding the following virulence factors: pyelonephritis-associated pili (pap); S fimbriae (sfa); afimbrial adhesin I (afaI); haemolysin (hly); cytotoxic necrotizing factor I (cnfI); and aerobactin (aer). It was observed that the virulence genes increased antibiotic resistance of resistant strains and increased the sensitivity of susceptible strains.

authors

Arisoy M,Rad AY,Akin A,Akar N

doi

10.1016/j.ijantimicag.2007.07.030

subject

Has Abstract

pub_date

2008-02-01 00:00:00

pages

S4-8

eissn

0924-8579

issn

1872-7913

pii

S0924-8579(07)00381-0

journal_volume

31 Suppl 1

pub_type

杂志文章
  • Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.

    abstract::The activity of six fluoroquinolones (FQs) was determined against 100 methicillin-resistant Staphylococcus aureus (MRSA) isolated in 2002 along with mutations in the grlA and gyrA genes and in the norA promoter of these isolates. Of the isolates tested, 97% had mutations in grlA and gyrA. A single mutation in grlA and...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2004.11.016

    authors: Noguchi N,Okihara T,Namiki Y,Kumaki Y,Yamanaka Y,Koyama M,Wakasugi K,Sasatsu M

    更新日期:2005-05-01 00:00:00

  • Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease.

    abstract::Amphotericin B is a powerful polyene antifungal drug used for treating systemic fungal infections and is usually administered for a short period. Side effects after prolonged use are unknown in humans. Here we report the case of a 28-year-old man suffering from chronic granulomatous disease (CGD), treated for invasive...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2014.02.015

    authors: Michot JM,Gubavu C,Fourn E,Maigne G,Teicher E,Angoulvant A,Blanche S,Lortholary O,Coilly A,Duclos-Vallée JC,Sebagh M,Guettier C,Aumont C,Delfraissy JF,Lambotte O

    更新日期:2014-06-01 00:00:00

  • Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.

    abstract::Staphylococcus aureus (S. aureus), including methicillin-resistant S. aureus (MRSA), is an important aetiological cause of community-acquired pneumonia (CAP) and associated with significant morbidity and mortality. Empiric therapy for CAP frequently consists of β-lactam monotherapy or β-lactam/macrolide combination th...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijantimicag.2019.08.012

    authors: Welte T,Kantecki M,Stone GG,Hammond J

    更新日期:2019-10-01 00:00:00

  • Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone.

    abstract::The tet(X) gene encodes a flavin-dependent monooxygenase that confers resistance to all clinically relevant tetracycline antibiotics including tigecycline. It has only previously been identified in environmental and non-human pathogenic bacteria. To investigate levels of multidrug resistance in Bo, Sierra Leone, a mol...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2013.04.014

    authors: Leski TA,Bangura U,Jimmy DH,Ansumana R,Lizewski SE,Stenger DA,Taitt CR,Vora GJ

    更新日期:2013-07-01 00:00:00

  • Multidrug-resistant high-risk Enterococcus faecium clones: can we really define them?

    abstract::Enterococcus faecium is a significant opportunistic human pathogen with a broad host range, including humans, farm animals, pets and wildlife. Specialised subpopulations have globally evolved towards a powerful and convergent adaption to the healthcare environment by acquiring a cocktail of key antimicrobial resistanc...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijantimicag.2020.106227

    authors: Freitas AR,Pereira AP,Novais C,Peixe L

    更新日期:2021-01-01 00:00:00

  • Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.

    abstract::Nosocomial infections caused by multidrug-resistant (MDR) microorganisms are a common problem around the world, especially in Intensive Care Units. The aim of this study was to investigate the efficacy and safety of colistin therapy in paediatric patients with severe nosocomial infections caused by MDR Gram-negative b...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.ijantimicag.2012.04.010

    authors: Paksu MS,Paksu S,Karadag A,Sensoy G,Asilioglu N,Yildizdas D,Akyildiz BN,Kendirli T,Demirkol D,Akgun M,Alp E,Ciftci E,Guney AK,Murat N

    更新日期:2012-08-01 00:00:00

  • Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice.

    abstract::Bumped kinase inhibitors (BKIs) are effective against a variety of apicomplexan parasites. Fifteen BKIs with promising in vitro efficacy against Neospora caninum tachyzoites, low cytotoxicity in mammalian cells, and no toxic effects in non-pregnant BALB/c mice were assessed in pregnant mice. Drugs were emulsified in c...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.106099

    authors: Anghel N,Winzer PA,Imhof D,Müller J,Langa X,Rieder J,Barrett LK,Vidadala RSR,Huang W,Choi R,Hulverson MA,Whitman GR,Arnold SL,Van Voorhis WC,Ojo KK,Maly DJ,Fan E,Hemphill A

    更新日期:2020-09-01 00:00:00

  • Application of pharmacokinetic/pharmacodynamic modelling and simulation for the prediction of target attainment of ceftobiprole against meticillin-resistant Staphylococcus aureus using minimum inhibitory concentration and time-kill curve based approaches.

    abstract::The purpose of this report was to compare two different methods for dose optimisation of antimicrobials. The probability of target attainment (PTA) was calculated using Monte Carlo simulation to predict the PK/PD target of fT>MIC or modelling and simulation of time-kill curve data. Ceftobiprole, the paradigm compound,...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2013.08.016

    authors: Barbour AM,Schmidt S,Zhuang L,Rand K,Derendorf H

    更新日期:2014-01-01 00:00:00

  • Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.

    abstract::This paper presents the results of a pilot study of difficult-to-treat patients (exhibiting several previous treatment failures or detection of extended-spectrum beta-lactamase [ESBL] strains) with chronic bacterial prostatitis (CBP) who underwent treatment with fosfomycin trometamol (FT) and N-acetyl-L-cysteine (NAC)...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.105935

    authors: Cai T,Tamanini I,Mattevi D,Verze P,Palmieri A,Malossini G,Mirone V,Novelli A,Tascini C,Johansen TEB

    更新日期:2020-07-01 00:00:00

  • Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2.

    abstract::Carbapenemase-producing (CP) Pseudomonas aeruginosa is rare compared with mutation-driven carbapenem-resistance, but this situation may be changing. A collection of CP P. aeruginosa isolates was characterized in this study. In 2016, 232 unduplicated carbapenem-resistant P. aeruginosa isolates, of which 71 (30.6%) carr...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.106026

    authors: PÉrez-VÁzquez M,Sola-Campoy PJ,Zurita ÁM,Ávila A,GÓmez-Bertomeu F,SolÍs S,LÓpez-Urrutia L,GÓnzalez-BarberÁ EM,Cercenado E,Bautista V,Lara N,Aracil B,Oliver A,Campos J,Oteo-Iglesias J,Spanish Antibiotic Resistance Surveillan

    更新日期:2020-07-01 00:00:00

  • Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China.

    abstract::The impact of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae of food animal origins on human health has caught considerable attention worldwide. Intestinal Escherichia coli obtained from healthy food animals (pigs, cattle and poultry) in China were tested for the presence of ESBL genes. CTX-M-produc...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2011.12.001

    authors: Zheng H,Zeng Z,Chen S,Liu Y,Yao Q,Deng Y,Chen X,Lv L,Zhuo C,Chen Z,Liu JH

    更新日期:2012-04-01 00:00:00

  • Octenidine: Novel insights into the detailed killing mechanism of Gram-negative bacteria at a cellular and molecular level.

    abstract::Octenidine (OCT) is a widely used antiseptic molecule with an antimicrobial spectrum covering a broad range of bacteria and fungi. However, the detailed molecular mechanism of killing has not yet been elucidated. The objective of our study was to investigate the mode of action of OCT's potent effect on Gram-negative b...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.106146

    authors: Malanovic N,Ön A,Pabst G,Zellner A,Lohner K

    更新日期:2020-11-01 00:00:00

  • Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.

    abstract::The chequerboard technique was used to look for synergistic combinations of ceftazidime, imipenem and pefloxacin. The synergistic combinations were used in vivo in mice experimentally infected with Escherichia coli, Salmonella typhimurium and Pseudomonas aeruginosa. In vitro ceftazidime/imipenem, ceftazidime/pefloxaci...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/s0924-8579(03)00127-4

    authors: El-Sukhon SN,Faiza Boukhatem Z

    更新日期:2003-12-01 00:00:00

  • Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

    abstract::This study was conducted to assess the clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. A total of 53 patients were included in the study. Forty-five patients (84.9%) received appropriate antibiotic therapy. Initial empirical treatment was appropriate i...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2005.06.012

    authors: Metan G,Zarakolu P,Cakir B,Hascelik G,Uzun O

    更新日期:2005-09-01 00:00:00

  • Staphylococcus aureus bacteraemia with known sources.

    abstract::Meticillin-resistant Staphylococcus aureus (MRSA), both hospital-acquired and community-acquired MRSA (CA-MRSA) strains, have increased in frequency in the last few years, reaching epidemic dimensions. This review discusses several clinical forms of staphylococcal infection leading to bacteraemia in a high proportion ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijantimicag.2008.06.006

    authors: Rubinstein E

    更新日期:2008-11-01 00:00:00

  • In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.

    abstract::Fluoroquinolones (FQs) are highly effective for treating tularaemia, a zoonosis caused by Francisella tularensis, but failures and relapses remain common in patients with treatment delay or immunocompromised status. FQ-resistant strains of F. tularensis harboring mutations in the quinolone-resistance determining regio...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2017.03.022

    authors: Sutera V,Hoarau G,Renesto P,Caspar Y,Maurin M

    更新日期:2017-09-01 00:00:00

  • Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.

    abstract::The effect of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to uroepithelial cells of Escherichia coli strains was investigated. The hydrophobicity of the tested strains was evaluated by the bacterial adherence to hydrocarbon-xylene test and by the salt aggregation test...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2007.01.007

    authors: Wojnicz D,Jankowski S

    更新日期:2007-06-01 00:00:00

  • Study of beta-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae.

    abstract::Mechanisms and transferability of beta-lactam resistance in 50 ceftazidime resistant strains of Enterobacteriaceae was studied. These strains were selected from 1991 E. coli, 1035 Enterobacter spp., 168 Citrobacter spp. and 1371 Klebsiella spp., isolated from patients hospitalized in ICUs and in the pediatric and urol...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/s0924-8579(98)00027-2

    authors: Bujdáková H,Lausová A,Jankovicová S,Prodinger WM,Kallová J,Milosovic P,Kettner M

    更新日期:1998-05-01 00:00:00

  • Novel anti-microbial therapies for dental plaque-related diseases.

    abstract::Control of dental plaque-related diseases has traditionally relied on non-specific removal of plaque by mechanical means. As our knowledge of oral disease mechanisms increases, future treatment is likely to be more targeted, for example at small groups of organisms, single species or at key virulence factors they prod...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijantimicag.2008.07.014

    authors: Allaker RP,Douglas CW

    更新日期:2009-01-01 00:00:00

  • An intervention programme for the management of multidrug-resistant tuberculosis in France.

    abstract::As shown in a previous study, the outcome of multidrug-resistant tuberculosis (MDR-TB) in France is not satisfactory (41% success rate). To improve the management and outcome of patients with MDR-TB, a prospective intervention study was carried out in 1998-1999 by National Reference Centre (NRC) staff. NRC staff conta...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2006.11.023

    authors: Uffredi ML,Truffot-Pernot C,Dautzenberg B,Renard M,Jarlier V,Robert J

    更新日期:2007-04-01 00:00:00

  • In vivo development of tigecycline resistance in Klebsiella pneumoniae owing to deletion of the ramR ribosomal binding site.

    abstract::Tigecycline resistance is emerging among Klebsiella pneumoniae, but knowledge regarding in vivo development of tigecycline resistance is limited. Here we report a new mechanism of tigecycline resistance in K. pneumoniae that evolved during tigecycline therapy. Klebsiella pneumoniae isolates were consecutively obtained...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2017.04.024

    authors: Ye M,Ding B,Qian H,Xu Q,Jiang J,Huang J,Ou H,Hu F,Wang M

    更新日期:2017-10-01 00:00:00

  • Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.

    abstract::Treatment options for multidrug-resistant (MDR) strains of Acinetobacter baumannii that acquire resistance to colistin are limited. Acinetobacter baumannii can become highly resistant to colistin through complete loss of lipopolysaccharide (LPS) owing to mutations in the genes encoding the first three enzymes involved...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2015.07.017

    authors: García-Quintanilla M,Carretero-Ledesma M,Moreno-Martínez P,Martín-Peña R,Pachón J,McConnell MJ

    更新日期:2015-12-01 00:00:00

  • Sex-dependent metabolism of nevirapine in rats: impact on plasma levels, pharmacokinetics and interaction with nortriptyline.

    abstract::Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) widely used in the treatment of human immunodeficiency virus type 1 (HIV-1) and is the first-choice NNRTI during pregnancy. NVP shows a sex dimorphic profile in humans with sex differences in bioavailability, biotransformation and toxicity. I...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2017.12.026

    authors: Usach I,Compañ P,Peris JE

    更新日期:2018-05-01 00:00:00

  • Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models.

    abstract::In vitro pharmacokinetic models are excellent tools with which to study an antibacterial's pharmacodynamics (pD), being flexible, adaptable, low cost, and correlating well with animal and human systems. They can be used to perform simple descriptive studies on antibacterial effect, determine the dominant pD factor and...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/s0924-8579(02)00027-4

    authors: MacGowan A,Bowker K

    更新日期:2002-04-01 00:00:00

  • In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.

    abstract::The ability of antibiotics used in bronchopulmonary infections in cystic fibrosis (CF) patients to prevent Pseudomonas aeruginosa early biofilm formation was studied using a biofilm microtitre assay with 57 non-mucoid P. aeruginosa isolates (44 first colonisers and 13 recovered during the initial intermittent colonisa...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2012.04.006

    authors: Fernández-Olmos A,García-Castillo M,Maiz L,Lamas A,Baquero F,Cantón R

    更新日期:2012-08-01 00:00:00

  • Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).

    abstract::Around the world, Staphylococcus aureus remains a dominant cause of bacteraemia. Whilst meticillin resistance remains the major phenotype of concern, various levels of reduced glycopeptide susceptibility are emerging with increasing frequency. The most common MRSA phenotypes now have raised vancomycin MICs within the ...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章,评审

    doi:10.1016/j.ijantimicag.2013.04.006

    authors: Gould IM

    更新日期:2013-06-01 00:00:00

  • Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model.

    abstract::Nacubactam is a novel non-β-lactam diazabicyclooctane β-lactamase inhibitor under development for the treatment of serious Gram-negative infections. This study assessed the efficacy of human-simulated epithelial lining fluid (ELF) exposure of nacubactam in combination with meropenem against AmpC-overproducing (n=4) an...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2019.10.019

    authors: Asempa TE,Motos A,Abdelraouf K,Bissantz C,Zampaloni C,Nicolau DP

    更新日期:2020-02-01 00:00:00

  • Genetic diversity of Streptococcus pneumoniae in Tunisia.

    abstract:OBJECTIVES:This study aimed to explore the genetic diversity of Streptococcus pneumoniae isolates in a Tunisian pneumology hospital. METHODS:A total of 141 S. pneumoniae strains isolated between 2009-2016 in the microbiology laboratory at A. Mami Hospital of Pneumology were investigated. Antimicrobial susceptibility t...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2018.09.023

    authors: Midouni B,Mehiri E,Ghariani A,Draoui H,Essalah L,Bouzouita I,Raoult D,Slim-Saidi L,Fournier PE

    更新日期:2019-01-01 00:00:00

  • Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates.

    abstract::Twenty-five years after its introduction, ceftazidime remains the most active cephalosporin against Pseudomonas aeruginosa. Nevertheless, resistance arises by upregulation of AmpC beta-lactamase, by efflux or, less often, via acquisition of additional beta-lactamases. Mutational resistance is especially prevalent amon...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2009.03.021

    authors: Livermore DM,Mushtaq S,Ge Y,Warner M

    更新日期:2009-11-01 00:00:00

  • Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin.

    abstract::A recent report identified significant reductions or disappearance of viral load in COVID-19 patients given a combination of hydroxychloroquine and azithromycin. The present communication discusses some common pharmacokinetic properties of these two drugs that may be linked to a potential underlying mechanism of actio...

    journal_title:International journal of antimicrobial agents

    pub_type: 杂志文章

    doi:10.1016/j.ijantimicag.2020.106007

    authors: Derendorf H

    更新日期:2020-06-01 00:00:00